Efficacy, Sustainability and Longevity
As the leading manufacturer and supplier of the world’s medical propellants, a vital component within Metered Dose Inhalers (pMDI), Koura offers a product portfolio which delivers efficacy, sustainability and performance.
The successful progress of our low GWP propellant Zephex 152a in testing and our recent investment in Zephex 152a production capability means that we have undertaken a review of our product portfolio and decided that Zephex 227ea, a small volume but higher GWP propellant no longer matches the profile that we consider right for Koura to supply. As such in the coming months Koura will no longer offer 227ea in its Zephex product range and will cease to supply Zephex 227ea from the start of 2021. We have informed all customers of this change.
Koura is committed to a sustainable future and supporting our customers in delivering sustainable products that Advance Life. Through our investment and early adoption of Zephex 152a, and continued support and supply of Zephex 134a, Koura will have a product portfolio which offers real environmental benefits for the pMDI platform for years to come.